Revenue
2021
2022
2023
2024
Eden Biosolutions plc (EDEN)
Price—Loading quote
Net income
2021
2022
2023
2024
Free cash flow
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue | £4.3M | £3.2M | £1.8M | £1.2M |
| Operating expenses | £4.1M | £3.6M | £3.4M | £3.8M |
| Operating income | −£2.2M | −£1.9M | −£2.6M | −£3.2M |
| Operating margin | −50.81% | −58.48% | −140.49% | −261.14% |
| EBITDA | −£1.6M | −£1.3M | −£1.9M | −£2.8M |
| EBITDA margin | −36.89% | −41.44% | −101.69% | −225.76% |
| Net income | −£1.9M | −£6.5M | −£2.2M | −£2.8M |
| Net profit margin | −44.31% | −203.45% | −122.44% | −227.01% |
| Basic EPSper basic share | N/A | -£0.02 | -£0.01 | -£0.01 |
| Diluted EPSper diluted share | N/A | -£0.02 | -£0.01 | -£0.01 |
Owners
Reported major voting-rights holders
11.40%of voting rights
Octopus Investments LimitedNotified Apr 13, 2026
View holders
| Holder | Voting rights |
|---|---|
| 11.40%Apr 13, 2026 · 91.55M votes |
These are threshold-crossing notices, not a complete ownership register. Percentages show issuer voting rights held through the listed share class, exclude financial instruments, and come from different dates. Positions may overlap.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: FCA voting-rights notice ↗Updated Oct 21, 2026